Leukemia transplant study tests lower radiation for better outcomes

NCT ID NCT06803745

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial tests whether a lower dose of total body irradiation (200 cGy) before a bone marrow transplant works as well as a standard higher dose (400 cGy) for people with acute leukemia. The goal is to see which dose leads to fewer severe side effects like graft-versus-host disease and better survival without relapse. About 160 participants will be randomly assigned to one of the two radiation doses as part of their transplant preparation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
total body irradiation (TBI) at 200 or 400 cGy
What this could lead to
If it works, this could identify the best radiation dose to reduce severe complications and improve long-term survival after transplant for leukemia patients.
What could go wrong
This is a phase 2 trial with only 160 participants, so results may not apply to everyone. Radiation can cause side effects, and the lower dose might not control the disease as well.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    RECRUITING

    Baltimore, Maryland, 21287, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.